Skip to content
$
0.00
0
Cart
Search
(780) 448-0585
IOT.V 0.25 0.00 0.00%
Services
By Application
Anti-Adherence
Anti-Encrustation Testing
Antimicrobials
Environmental Bioburden Monitoring
Facility Water Testing
GMP Analytical Chemistry Testing Services
Medical Device Testing
MIC, MBC, MFC, Toxicology Testing
Microbiology Testing Services
Pharmaceutical & Drug Development
Stability Testing Services
Sterility Testing
By Method
Antimicrobial Effectiveness Testing USP <51>
BEST Assay™ Method
Environmental Bioburden Monitoring
GMP Analytical Chemistry Testing Services
MBEC Assay® Testing
Method Development and Validation Services
MIC, MBC, MFC, Toxicology Testing
By Industry
Compounding Pharmacies
Medical Device Testing
Pharmaceutical & Drug Development
Products
MBEC
InnovoSIL
Resources
Investor Relations
Company
Our Team / History
Careers
Quality
Contact
Contact Us
News
May 21, 2024
Q1-2024 Results
April 24, 2024
Innovotech Reports a Loss for Fiscal 2023
March 31, 2024
Interim Financial Statements & MD&A for period ended 31 March 2024
December 31, 2023
Annual Financial Statements & MD&A For the 2023 year ended December 31
December 12, 2023
Innovotech CFO
November 28, 2023
Innovotech AICE Grant
September 30, 2023
Interim Financial Statements & MD&A for period ended 30 September 2023
August 25, 2023
Innovotech Closes Majority Stake in Nou Life Skincare Technology
August 15, 2023
Innovotech Reports a Profitable Second Quarter Ended June 30th, 2023
August 1, 2023
Notice of Grant of Third Party Option by Control Person
July 17, 2023
Innovotech Appoints Dr. Craig Milne as Chief Executive Officer
June 30, 2023
Interim Financial Statements & MD&A for period ended 30 June 2023
Page
1
Page
2
Page
3
Page
4
Page
5